• LDS
  • /Medical Tests
  • /Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management

Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
Medical Test

Diseases (2)
Access to Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management is restricted.

Overview
Access to Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management is restricted.

Clinical Utility
Access to Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management is restricted.

Interpretation
Access to Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management is restricted.

Reference Ranges
Access to Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management is restricted.

Methodology
Access to Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management is restricted.

Specimen Collection
Access to Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management is restricted.

Additional Testing
Access to Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management is restricted.

Turnaround Time
Access to Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management is restricted.

CPT
Access to Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management is restricted.

LOINC
Access to Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management is restricted.

ICD10
Access to Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management is restricted.

Additional ICD10
Access to Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management is restricted.

References
Access to Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management is restricted.

Panel Test Components
Access to Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management is restricted.